Molecular MR imaging of melanoma angiogenesis with α νβ3-targeted paramagnetic nanoparticles

Magnetic Resonance in Medicine

Volumn 53, Issue 3, 2005, Pages 621-627

  Schmieder, Anne H ^a   Winter, Patrick M ^b   Caruthers, Shelton D ^b,c   Harris, Thomas D ^d   Williams, Todd A ^b   Allen, John S ^b   Lacy, Elizabeth K ^b   Zhang, Huiying ^b   Scott, Michael J ^b   Hu, Grace ^b   Robertson, J David ^e   Wickline, Samuel A ^a,b   Lanza, Gregory M ^a,b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

Angiogenesis; Magnetic resonance; Melanoma; Molecular imaging; Targeted contrast agent

Indexed keywords

CELL ADHESION; DERMATOLOGY; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAMMALS; NANOPARTICLES; ONCOLOGY; PARAMAGNETISM; TUMORS;

ANGIOGENESIS; CELL-ADHESION ASSAYS; CONTRAST ENHANCEMENT; MELANOMA; MELANOMA XENOGRAFTS; NEO-VASCULARIZATION; TARGETED CONTRAST AGENTS; TARGETED NANOPARTICLE;

MOLECULAR IMAGING;

GADOLINIUM PENTETATE BISOLEATE; GADOLINIUM PENTETATE DERIVATIVE; MACROGOL 200; N [[OMEGA [4 (4 MALEIMIDOPHENYL)BUTANOYL]AMINO]MACROGOL] 1,2 DISTEAROYLGLYCERO 3 PHOSPHOETHANOLANINE; NANOPARTICLE; RECEPTOR BLOCKING AGENT; SURFACTANT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; VITRONECTIN RECEPTOR BLOCKING AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CELL ADHESION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EARLY DIAGNOSIS; HISTOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MATERIAL COATING; MELANOMA; MOLECULAR IMAGING; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PARAMAGNETIC NANOPARTICLE; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 20044390737     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20391     Document Type: Article

References (34)

1. Gillies RJ. In vivo molecular imaging. J Cell Biochem Suppl 2002;39:231-238.
2. Herschman HR. Molecular imaging: looking at problems, seeing solutions. Science 2003;302:605-608.
3. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-580.
4. Wickline SA, Lanza GM. Molecular imaging, targeted therapeutics, and nanoscience. J Cell Biochem Suppl 2002;39:90-97.
5. Srivastava A, Ralhan R, Kaur J. Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech 2003;60:208-224.
6. Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma. Mol Med 1999;5:785-794.
7. Welzel J, Reinhardt C, Lankenau E, Winter C, Wolff HH. Changes in function and morphology of normal human skin: evaluation using optical coherence tomography. Br J Dermatol 2004;150:220-225.
8. Lanza GM, Lorenz CH, Fischer SE, Scott MJ, Cacheris WP, Kaufmann RJ, Gaffney PJ, Wickline SA. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol 1998;5(Suppl 1):S173-S176.
9. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alphavbeta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003;63:5838-5843.
10. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001;104:1280-1285.
11. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003;50:411-416.
12. Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;51:480-486.
13. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003;108:2270-2274.
14. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994;264:569-571.
15. Stupack DG, Cheresh DA. ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci STKE 2002;2002:PE7.
16. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997;15:542-546.
17. Harris TD, Kalogeropoulos S, Nguyen T, Liu S, Bartis J, Ellars C, Edwards S, Onthank D, Silva P, Yalamanchili P, Robinson S, Lazewatsky J, Barrett J, Bozarth J. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother Radiopharm 2003;18:627-641.
18. Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA. Quantitative "magnetic resonance immunohistochemistry" with ligand targeted 19F nanoparticles. Magn Reson Med 52:1255-1262.
19. Aumailley M, Mann K, von der Mark H, Timpl R. Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha 2(VI) and alpha 3(VI) chains. Exp Cell Res 1989;181:463-474.
20. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989;182:16-19.
21. Zee CS, Segall HD, Terk MR, Destian S, Ahmadi J, Gober JR, Colletti PM. SPIR MRI in spinal diseases. J Comput Assist Tomogr 1992;16:356-360.
22. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
23. Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000;44:433-439.
24. Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, Su H, Edwards DS, Liu S, Harris TD, Madri JA, Zaret BL, Sinusas AJ. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004;113:1684-1691.
25. Thomas JM, Newton-Bishop J, A'Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield M, O'Neill T, Ruka W, Bliss JM. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757-766.
26. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ. Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 2002;106:2842-2847.
27. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-381.
28. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer FS, Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-752.
29. van Leeuwen RL, Yoshinaga IG, Akasaka T, Dekker SK, Vermcer BJ, Byers HR. Attachment, spreading and migration of melanoma cells on vitronectin. The role of alpha V beta 3 and alpha V beta 5 integrins. Exp Dermatol 1996;5:308-315.
30. Nip J, Brodt P. The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis. Cancer Metastasis Rev 1995;14:241-252.
31. Felding-Habermann B, Ruggeri ZM, Cheresh DA. Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 1992;267:5070-5077.
32. Cheresh DA. Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells. Cancer Metastasis Rev 1991;10:3-10.
33. Cheresh DA, Pytela R, Pierschbacher MD, Klier FG, Ruoslahti E, Reisfeld RA. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. J Cell Biol 1987;105:1163-1173.
34. Juhasz I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Valyi-Nagy IT, Herlyn M. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 1993;143:537.